Navigation Links
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

n blood pressure medications such as ACE inhibitors or diuretics.

"For this patient population, patients who failed biologic therapies, their bones and joints appear to respond to R788, but the objective and subjective components of the ACR and DAS28 scores are incongruent, mainly because the reported subjective placebo response rates were higher than expected," said Elliott Grossbard, M.D., chief medical officer for Rigel. "Nonetheless, R788 is well tolerated and its side effects appear generally manageable, and we look forward to planning our Phase 3 program for R788 with a corporate partner," he added.

    Safety Results Tables
                                              Placebo         100 mg bid
                                              -------         ----------
    N                                            73              146
    ---                                         ---              ---
    Dose Reductions                          N         %        N         %
    ---------------                        ---       ---      ---       ---
    # Had a Dose Reduction                   2        3%       21       14%
    ----------------------                 ---       ---      ---       ---
    Neutropenia (ANC less than 1500)         0        0%        3        2%
    --------------------------------       ---       ---      ---       ---
    Diarrhea, nausea, vomiting,
     dizziness                               1        1%        7        5%
    ---------------------------            ---       ---      ---       ---
    Increase in Blood Pressure (BP)          1        1%        7        5%
    -------------------------------        ---       ---      ---       ---
    ALT or Alkphos Elevation                 0        0%        4        3%
    ------------------------               ---       ---      ---       ---

    TASKi3 Treatment Emergent Adverse Events

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2, 2011 The Center for Radiation Therapy of ... patients in the Los Angeles area, has been awarded ... the result of a recent review by the American ... Radiation Oncology (ASTRO). Radiation oncology (radiation ...
... Va., March 2, 2011 Insmed Incorporated (Nasdaq: ... the one-for-10 reverse stock split of Insmed,s Common Stock ... 2, 2011, after the State Corporation Commission of the ... of Incorporation to effect the reverse stock split.  The ...
Cached Medicine Technology:The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 2The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 3One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective 2
(Date:12/21/2014)... 2014’s new collection of 2015 ... total of 1,000 new designs in this collection, and ... 2015. , promises to provide the ... wardrobe essentials while many fashion trends come and go. ... service team at is ready to assist. ...
(Date:12/21/2014)... Recently, one of the best prom dresses online ... has introduced its new collection of 2015 prom dresses, ... all its prom dresses & other fashionable designs, up ... top quality dress products and great customer services to ... of the best prom dresses online shops around the ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage ... and the Doors International Ballroom at the Hilton Hotel ... the only time that Morrison's mother would see her ... 1967. According to Hawley, “This would be the Doors ... Alexandria Roller Rink earlier that year and would return ...
(Date:12/21/2014)... December 21, 2014 SCI ... the issues and systemic barriers for disabled athletes with ... Champion. Scheidies has a condition called juvenile macular degeneration, ... describes how he adapted his athletic ambitions to his ... success in triathlon to pioneer the way for other ...
(Date:12/21/2014)... December 21, 2014 celebrates marijuana’s new ... The only one of its kind, the site has provided ... marijuana for 14 years running. It uniquely combines the ... make cannabis readily available to the masses. Assuring the ... the golden ring of public approval. , Shane ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... years back Dr Stephen Elliott was the radiologist consultant ... were expressed by Department of Health chiefs about the ... hospital authorities made his payment and also reduced his ... prompted by concerns raised by clinical staff in Antrim ...
... and alcohol team is now appointed to chair the Scottish ... Scotland suffers from an increase in the number of people ... as the head of SAADAT at the first meeting of ... a group which consists of both the former Scottish Association ...
... asked the pharmaceuticals companies and academic institutions to reveal all ... drug trails including the details about Phase I trials, initial ... be registered on independent registers as soon as they begin. ... is to spark mixed reaction among the researchers. ...
... many people’s problems comes a theory that tells why people ... studied brain scans to elucidate that there are centres in ... ads featuring food and packets of food product. , ... is likely that people over-eating, and become obese. ...
... to prevent or reduce public smoking. This is another step ... money would pay for 100 enforcement officers in the province. ... enclosed spaces which is common to public. , ... would help the people to quit smoking, discourage young people ...
... that the deadly strain H5N1 strain of bird flu has ... in Siberia all infected with the H5N1 strain.// The regional ... from Omsk region. , The samples of the ... biotechnology centre Vektor, for inspection. Ilya Drozdov, the centre's general ...
Cached Medicine News:Health News:The persistent urge to eat: Loose control!!! 2
... The TL-100 uses technology that takes ... by automatically detecting and reading them. It ... recording the results, mark lenses as you ... contact lenses. Easy to use, the TL-100 ...
... The Kowa RC-XV3 camera is ... The automatic exposure system, ... sensitivity, the 2.5~300ws watt indication ... handling are the basic features ...
FF 450plus fundus camera for 35mm photography. Upgradeable basic instrument for brilliant image quality....
The new TRC-NW6 non-mydriatic retinal camera is the ideal instrument for the growing market in telemedicine and diabetic screening....
Medicine Products: